CLLS - Cellectis S.A.

QQQ $ 452.92 $ -0.60 (-0.13 %)

DIA $ 399.63 $ 0.35 (0.09 %)

SPY $ 529.52 $ -0.41 (-0.08 %)

TLT $ 92.10 $ -0.29 (-0.31 %)

GLD $ 220.26 $ -0.63 (-0.29 %)

Previous Close

$ 3.06

Open

$ 2.98

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.98 - $ 2.98

52 Week Range

$ 0.96 - $ 3.77

Volume

11,339

Average Volume

Market Cap

219.56M

Beta (5Y Monthly)

$ 2.04

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
05/07/2024 12:06:20

Cellectis Announces Completion Of AstraZen...
05/06/2024 08:11:35

As part of the Additional Investment, AstraZeneca subscribed today for 10,000,000 "class A" convertible preferred share...

Cellectis Appoints Arthur Stril As Interim...
05/02/2024 21:35:55

Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platf...

Cellectis Q4 2023 GAAP EPS $(0.64) Misses ...
04/29/2024 20:49:30

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.26) b...

Cellectis To Present Data On TALEN Editing...
04/22/2024 20:38:50

Cellectis Publishes Novel Intronic Gene Ed...
04/10/2024 20:31:47

Cellectis Announces Two Poster Presentatio...
04/08/2024 20:36:46

Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platf...

Cellectis Announces The Execution Of The S...
11/15/2023 08:26:20

Cellectis Q3 2023 Adj EPS $(0.36) Beats $(...
11/06/2023 22:03:20

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.42) by ...

Earnings Scheduled For November 6, 2023
11/06/2023 13:24:53

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on ...

Earnings Preview: Cellectis
11/03/2023 19:01:17

Cellectis To Present Preliminary Results O...
11/02/2023 21:42:37

Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing plat...

why-staar-surgical-shares-are-trading-lower-by-around-16-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why STAAR Surgical Shares Are Trading Lowe...
11/02/2023 18:26:27

Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was a...

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
11/02/2023 13:05:59

Why Roku Shares Are Trading Higher By Arou...
11/02/2023 12:08:05

Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 39.7% to $0.1143 in pre-market trading after falling 17% on Wednesday. L...

Dow Gains Over 100 Points; Fed Leaves Inte...
11/01/2023 18:33:23

U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision. The Dow traded u...

why-extreme-networks-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Extreme Networks Shares Are Trading Lo...
11/01/2023 17:59:52

Gainers

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
11/01/2023 17:31:20

why-is-cancer-player-cellectis-stock-trading-over-100-higher-today

Why Is Cancer Player Cellectis Stock Tradi...
11/01/2023 17:20:28

Cellectis SA (NASDAQ: CLLS) shares are trading higher after the company

JMP Securities Reiterates Market Outperfor...
11/01/2023 16:58:25

JMP Securities analyst Silvan Tuerkcan reiterates Cellectis (NASDAQ:CLLS) with a Market Outperform and maintains $6 price ta...